Trial Profile
Investigation of Somatosensory Predictors of Response to Pregabalin in Painful Chemotherapy-induced Peripheral Neuropathy (CIPN)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 17 Sep 2018 Status changed from recruiting to completed.
- 31 Oct 2017 Planned End Date changed from 1 Dec 2017 to 1 Feb 2019.
- 31 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Dec 2018.